Italy Hereditary Angioedema Therapeutics Market Size & Outlook
Italy hereditary angioedema therapeutics market, 2018-2030 (US$M)
Related Markets
Italy hereditary angioedema therapeutics market highlights
- The Italy hereditary angioedema therapeutics market generated a revenue of USD 92.9 million in 2023 and is expected to reach USD 214.6 million by 2030.
- The Italy market is expected to grow at a CAGR of 12.7% from 2024 to 2030.
- In terms of segment, kallikrein inhibitor was the largest revenue generating treatment in 2023.
- Kallikrein inhibitor is the most lucrative treatment segment registering the fastest growth during the forecast period.
Hereditary angioedema therapeutics market data book summary
| Market revenue in 2023 | USD 92.9 million |
| Market revenue in 2030 | USD 214.6 million |
| Growth rate | 12.7% (CAGR from 2023 to 2030) |
| Largest segment | Kallikrein inhibitor |
| Fastest growing segment | Kallikrein inhibitor |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | C1-esterase inhibitor, Bradykinin B2 receptor antagonist, Kallikrein inhibitor, Others Treatment |
| Key market players worldwide | BioCryst Pharmaceuticals Inc, Ionis Pharmaceuticals Inc, CSL Ltd, Adverum Biotechnologies Inc, KalVista Pharmaceuticals Inc, Takeda Pharmaceutical Co Ltd, Pharming Group, Attune Pharmaceuticals |
Other key industry trends
- In terms of revenue, Italy accounted for 3.3% of the global hereditary angioedema therapeutics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany hereditary angioedema therapeutics market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 276.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Hereditary Angioedema Therapeutics Market Scope
Hereditary Angioedema Therapeutics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Italy hereditary angioedema therapeutics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hereditary angioedema therapeutics market will help companies and investors design strategic landscapes.
Kallikrein inhibitor was the largest segment with a revenue share of 44.78% in 2023. Horizon Databook has segmented the Italy hereditary angioedema therapeutics market based on c1-esterase inhibitor, bradykinin b2 receptor antagonist, kallikrein inhibitor, others treatment covering the revenue growth of each sub-segment from 2018 to 2030.
The healthcare system in Italy is well-established, which is contributing to the growth of Italy hereditary angioedema therapeutics market. The country provides universal healthcare coverage benefits to its citizens.
However, the Italian government adopts special measures to ensure healthcare accessibility to the most vulnerable groups, such as those suffering from diseases. Moreover, the market growth can be attributed to the presence of local players and increasing research activities in the field of HAE drug development in the country.
Moreover, increasing R&D investments and continuous scientific research have boosted the demand for novel therapeutics in Italy. The healthcare system in the country is well established, which is contributing to the growth of Italian hereditary angioedema market.
Reasons to subscribe to Italy hereditary angioedema therapeutics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Italy hereditary angioedema therapeutics market databook
-
Our clientele includes a mix of hereditary angioedema therapeutics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy hereditary angioedema therapeutics market, including forecasts for subscribers. This country databook contains high-level insights into Italy hereditary angioedema therapeutics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Italy hereditary angioedema hae therapeutics market size, by treatment, 2018-2030 (US$M)
Italy Hereditary Angioedema Therapeutics Market Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
